To determine the diagnostic ability of PC screening, most previous studies included a screening modality (PSA or TRUS) to predict consequent positive results in prostate biopsy [7,11,12,13,14,15,16,35,36,37,38,39,40,41,42,43,44] (Table S3). Here, KLK3 is linked to pachyonychia congenita.